共 50 条
- [31] Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels[J]. CANCER RESEARCH, 2009, 69Dan, Shingo论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Tokyo, Japan Japanese Fdn Canc Res, Tokyo, JapanSugita, Hironobu论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Tokyo, Japan Japanese Fdn Canc Res, Tokyo, JapanYamazaki, Kanami论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Tokyo, Japan Japanese Fdn Canc Res, Tokyo, JapanYamori, Takao论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Tokyo, Japan Japanese Fdn Canc Res, Tokyo, Japan
- [32] Preclinical profile of novel, potent, and selective PI3K delta inhibitors[J]. CANCER RESEARCH, 2011, 71Vakkalanka, Swaroop论文数: 0 引用数: 0 h-index: 0机构: Incozen Therapeut, Hyderabad, Andhra Pradesh, India Incozen Therapeut, Hyderabad, Andhra Pradesh, IndiaMuthuppalaniappan, Meyyappan论文数: 0 引用数: 0 h-index: 0机构: Incozen Therapeut, Hyderabad, Andhra Pradesh, India Incozen Therapeut, Hyderabad, Andhra Pradesh, IndiaBabu, G.论文数: 0 引用数: 0 h-index: 0机构: Incozen Therapeut, Hyderabad, Andhra Pradesh, India Incozen Therapeut, Hyderabad, Andhra Pradesh, IndiaVaranasi, Kanthikiran V. S.论文数: 0 引用数: 0 h-index: 0机构: Incozen Therapeut, Hyderabad, Andhra Pradesh, India Incozen Therapeut, Hyderabad, Andhra Pradesh, IndiaVeeraraghavan, Sridhar论文数: 0 引用数: 0 h-index: 0机构: Incozen Therapeut, Hyderabad, Andhra Pradesh, India Incozen Therapeut, Hyderabad, Andhra Pradesh, IndiaViswanadha, Srikant论文数: 0 引用数: 0 h-index: 0机构: Incozen Therapeut, Hyderabad, Andhra Pradesh, India Incozen Therapeut, Hyderabad, Andhra Pradesh, India
- [33] Pharmacokinetics of selective PI3Kδ inhibitors after intratracheal instillation in mice[J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46Gunerka, Pawel论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandHucz-Kalitowska, Joanna论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandTurowski, Pawel论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandZagozda, Marcin论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandDziachan, Maciej论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandSekular, Mariola论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandBujak, Anna论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, PolandWieczorek, Maciej论文数: 0 引用数: 0 h-index: 0机构: Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland Celon Pharma SA, Innovat Drugs R&D Dept, Kielpin Lomianki, Poland
- [34] A class of highly selective inhibitors bind to an active state of PI3Kγ[J]. Nature Chemical Biology, 2019, 15 : 348 - 357Gangadhara Gangadhara论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitGöran Dahl论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitThomas Bohnacker论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitRebecca Rae论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitJenny Gunnarsson论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitStefan Blaho论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitLinda Öster论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitHelena Lindmark论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitKostas Karabelas论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitNils Pemberton论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitChristian Tyrchan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitMickael Mogemark论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitMatthias P. Wymann论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitRoger L. Williams论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitMatthew W. D. Perry论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitTineke Papavoine论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech UnitJens Petersen论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca,Discovery Sciences, IMED Biotech Unit
- [35] Quantum biochemistry description of PI3Kα enzyme bound to selective inhibitors[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,de Sousa, Francisca Joseli Freitas论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazil Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, BrazilAzevedo, Francisca Fernanda Nunes论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazil Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazilde Oliveira, Francisco Lucas Santos论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, Brazil Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, BrazilCarletti, Jaqueline Vieira论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, Brazil Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, BrazilFreire, Valder Nogueira论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Ceara, Dept Phys, Fortaleza, Brazil Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, BrazilZanatta, Geancarlo论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazil Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, Brazil Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazil
- [36] A class of highly selective inhibitors bind to an active state of PI3Kγ[J]. NATURE CHEMICAL BIOLOGY, 2019, 15 (04) : 348 - +Gangadhara, Gangadhara论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenDahl, Goran论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden论文数: 引用数: h-index:机构:Rae, Rebecca论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenGunnarsson, Jenny论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenBlaho, Stefan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenOster, Linda论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenLindmark, Helena论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenKarabelas, Kostas论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenPemberton, Nils论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenTyrchan, Christian论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenMogemark, Mickael论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Drug Safety & Metab, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenWymann, Matthias P.论文数: 0 引用数: 0 h-index: 0机构: Univ Basel, Dept Biomed, Basel, Switzerland AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenWilliams, Roger L.论文数: 0 引用数: 0 h-index: 0机构: MRC Lab Mol Biol, Cambridge, England AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenPerry, Matthew W. D.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenPapavoine, Tineke论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Resp Inflammat & Autoimmun, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, SwedenPetersen, Jens论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden AstraZeneca, IMED Biotech Unit, Discovery Sci, Gothenburg, Sweden
- [37] PI3K Inhibitors in Cardiovascular Disease[J]. CARDIOVASCULAR THERAPEUTICS, 2011, 29 (01) : 29 - 36Eisenreich, Andreas论文数: 0 引用数: 0 h-index: 0机构: Charite, Ctr Herz & Kreislaufmed, D-12200 Berlin, Germany Charite, Ctr Herz & Kreislaufmed, D-12200 Berlin, GermanyRauch, Ursula论文数: 0 引用数: 0 h-index: 0机构: Charite, Ctr Herz & Kreislaufmed, D-12200 Berlin, Germany Charite, Ctr Herz & Kreislaufmed, D-12200 Berlin, Germany
- [38] Discovery and optimization of a series of benzothiazole PI3K/mTOR dual inhibitors[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242D'Angelo, Noel D.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAKim, Tae-Seong论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAAndrews, Kristin论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USABooker, Shon K.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USACaenepeel, Sean论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAChen, Kui论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept High Throughput Screening & Mol Pharmacol, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAD'Amico, Derin论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAFreeman, Dan论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAJiang, Jian论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USALiu, Longbin论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAMcCarter, John D.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept High Throughput Screening & Mol Pharmacol, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAMiguel, Tisha San论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept High Throughput Screening & Mol Pharmacol, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAMullady, Erin L.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept High Throughput Screening & Mol Pharmacol, Cambridge, MA 02142 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USASchrag, Michael论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USASubramanian, Raju论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USATang, Jin论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Mol Struct, Cambridge, MA 02142 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAWahl, Robert C.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept High Throughput Screening & Mol Pharmacol, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAWang, Ling论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAWhittington, Douglas A.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Mol Struct, Cambridge, MA 02142 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAWu, Tian论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAXi, Ning论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAXu, Yang论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAYakowec, Peter论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Mol Struct, Cambridge, MA 02142 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAYang, Kevin论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAZalameda, Leeanne P.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept High Throughput Screening & Mol Pharmacol, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAZhang, Nancy论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USAHughes, Paul论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USANorman, Mark H.论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA Amgen Inc, Dept Med Chem, Thousand Oaks, CA 91320 USA
- [39] Horizons broaden for PI3Kδ inhibitors[J]. Nature Reviews Drug Discovery, 2014, 13 : 573 - 573Katie Kingwell论文数: 0 引用数: 0 h-index: 0
- [40] From lab to clinic: The discovery and optimization journey of PI3K inhibitors[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277Lian, Siyu论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R ChinaDu, Zhenhua论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R ChinaChen, Qingqing论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China论文数: 引用数: h-index:机构:Miao, Xinxin论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R ChinaYu, Weiwei论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Shengjing Hosp, Dept Anesthesiol, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R ChinaSun, Qian论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R ChinaFeng, Chong论文数: 0 引用数: 0 h-index: 0机构: China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang, Peoples R China